MannKind
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MannKind and other ETFs, options, and stocks.About MNKD
MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501.
MNKD Key Statistics
Stock Snapshot
MannKind(MNKD) stock is priced at $5.85, giving the company a market capitalization of 1.79B. It carries a P/E multiple of 59.70.
During the trading session on 2025-12-09, MannKind(MNKD) shares reached a daily high of $5.90 and a low of $5.63. At a current price of $5.85, the stock is +3.8% higher than the low and still -0.8% under the high.
Trading volume for MannKind(MNKD) stock has reached 2.25M, versus its average volume of 2.46M.
The stock's 52-week range extends from a low of $3.38 to a high of $7.07.
The stock's 52-week range extends from a low of $3.38 to a high of $7.07.
MNKD News
MannKind Corporation recently announced that the FDA has accepted its supplemental New Drug Application for the FUROSCIX ReadyFlow Autoinjector, an under-10-sec...
The latest move from MannKind (MNKD) is the FDA accepting its supplemental filing for the FUROSCIX ReadyFlow Autoinjector, a potential at home alternative for r...